| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| ALT | Alanine aminotransferase |
| ASE | Accelerated solvent extraction |
| AST | Aspartate aminotransferase |
| BBB | Blood–brain barrier |
| CAT | Catalase |
| COX-2 | Cyclooxygenase-2 |
| CUPRAC | Cupric ion reducing antioxidant capacity |
| CYPs | Cytochromes P50 |
| ED50 | Median effective dose |
| ESI | Electrospray ionization |
| FRAP | Ferric reducing ability of plasma |
| fEPSP | Field excitatory postsynaptic potentials |
| HSP | Heat shock proteins |
| HSF | Heat shock Factors |
| HT2A | Hydroxy-Tryptamine receptor |
| IC50 | Half maximal inhibitory concentration |
| I. P | Intraperitoneal |
| Keap1 | Kelch-like ECH-Associating protein 1 |
| Kg | Kilogram |
| LD50 | Median lethal dose |
| LPS | Lipopolysaccharides |
| LTP | Long-term potentiation |
| MAO | Monoamine oxidase |
| Mg | Milligram |
| µg | Microgram |
| MIC | Minimum inhibitory concentration |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| Nm | Nanometer |
| PD | Parkinson’s disease |
| P. O | Per Oral |
| QTOF-MS | Quadrupole time-of-flight mass spectrometry |
| SOD | Superoxide dismutase |
| TPC | Total phenolic content |
| TFC | Total flavonoid content |
| UDP | Uridine diphosphate |
| UGT | UDP-glucuronosyl transferase |
| UHPLC | Ultra high-performance liquid chromatography |
| w/w | Weight for weight |